Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.72) by 15.28 percent. This is a 39 percent increase over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $12.47 million which beat the analyst consensus estimate of $4.29 million by 190.65 percent. This is a 9.20 percent increase over sales of $11.42 million the same period last year.
ABM Industries Q1 Adj EPS $0.79 Beats $0.77 Estimate, Sales $1.99B Miss $2.02B Estimate
ABM Industries (NYSE:ABM) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.77 by 2.6 percent. This is a 15.96 percent decrease over earnings of $0.94 per share from the same
